News archive

Latest News from the Partnership

Poul Nissen, Director of DANDRITE receives the 2021 Anders Jahre Medical Prize. Photo credit: UiO/Jarli&Jordan

2021.11.29 | Awards

The future of science is interdisciplinary for Poul Nissen, Anders Jahre Medical Prize 2021 winner

Poul Nissen, Director of DANDRITE, received the Anders Jahre Senior Medical Prize 2021 in Oslo, Norway in November.

A multi-well plate containing different cancer drugs and a graphical drug sensitivity testing result. Photo credit: FIMM

2021.11.22 | Research news

Functional precision medicine using drug sensitivity testing enables tailoring of therapy for leukemia patients

A functional precision medicine study conducted in Finland demonstrates that treatment selection based on results from drug sensitivity testing of patients' cells can be clinically useful in patients with aggressive hematological cancers.

Alex Harvey in Oslo Science Park, Norway; Photo credit: Larissa Lily

2021.11.22 | PhD Course

Knowledge sharing across the Nordics: NCMM hosts national PhD course in Molecular Medicine

During 8-19 November, NCMM hosted its annual PhD course in Molecular Medicine, strengthening scientific exchange and interactions in the Nordic countries.

Anne-Marie Fors Connolly, key investigator of the scientific project. Credit: Mattias Petterson.

2021.11.16 | Awards

Funding awarded to Nordic collaboration for post-COVID studies

A collaboration with researchers affiliated with MIMS/Umeå University, FIMM/University of Helsinki and University of Copenhagen has been awarded funding from the Swedish Research Countil for studying clinical featuers and organ impact of post-COVID syndrome.

2021.11.14 | People

DANDRITE opens call for 1-2 new group leaders

The Danish node of the Nordic EMBL Partnership for Molecular Medicine, DANDRITE, seeks 1-2 new group leaders in molecular and translational neuroscience.